New Jersey-based Bausch Health Companies received premarket approval from the US Food and Drug Administration on 22 February for its StableVisc Ophthalmic Viscosurgical Device (OVD) – a transparent thick liquid used during cataract surgery.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?